Sensinnovat
VC Fund
Sensinnovat is a VC fund focused on Health Care and Manufacturing. Sensinnovat
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Sensinnovat invests in
Stages Sensinnovat invests in
Countries Sensinnovat invests in
Round sizes
Round size
- Seed
- $5.2M–$7.3M
- Series A
- $7.7M–$17M
Investment Focus
Industry
- Health Care 2 (40%)
- Manufacturing 2 (40%)
- Medical Device 2 (40%)
- Medical 1 (20%)
- Diabetes 1 (20%)
Stage
- Seed 2 (40%)
- Series A 2 (40%)
- Series B 1 (20%)
Country
- Belgium 2 (40%)
- France 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Hummink develops additive manufacturing technology designed to provide tools to design and manufacture at the nanoscale.It uses a patented technology that combines a nanometric pen with an oscillating microresonator to perform a capillary deposition of various liquids, thereby providing semiconductor molecular diagnostic industries with the toolsto build large objects with the same resolution and precision on millimetric to centimetric substrates.Amin M'barki, Pascal Boncenne, Lydéric Bocquet, Alessandro Siria, Antoine Nigues established the company in Paris, Île-de-France in 2020. | $17.4M / Series A / Nov 17, 2025 | |
|
|
Hummink develops additive manufacturing technology designed to provide tools to design and manufacture at the nanoscale.It uses a patented technology that combines a nanometric pen with an oscillating microresonator to perform a capillary deposition of various liquids, thereby providing semiconductor molecular diagnostic industries with the toolsto build large objects with the same resolution and precision on millimetric to centimetric substrates.Amin M'barki, Pascal Boncenne, Lydéric Bocquet, Alessandro Siria, Antoine Nigues established the company in Paris, Île-de-France in 2020. | $5.2M / Seed / Nov 15, 2022 | |
|
|
Azalea Vision is a medical manufacturer designing contact lenses with an active light management system for people with ocular disorders. | $7.3M / Seed / Jul 08, 2021 | |
|
|
Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology thatrevolutionized the Internet during the last decades and now aims at transforming diabetes management. | $44.7M / Series B / Jul 27, 2020 | |
|
|
Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology thatrevolutionized the Internet during the last decades and now aims at transforming diabetes management. | $7.7M / Series A / Dec 20, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sensinnovat invest in?
Sensinnovat invests primarily in Health Care, Manufacturing and Medical Device startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sensinnovat's check size?
Sensinnovat typically joins rounds of $5.2M–$7.3M at Seed and $7.7M–$17M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sensinnovat participates in.
When did Sensinnovat last invest?
The most recent investment recorded for Sensinnovat closed in Nov 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!